| Income Statement | 2025-06-30 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total other income (expense), net | -3 | - | - | |
| Loss before income taxes | -20,368 | -1,914 | -3,911 | |
| Income taxes (benefit) | 0 | - | - | |
| Net loss | -20,368 | -1,914 | -3,911 | |
| Non-controlling interest | 4 | - | 4 | |
| Net loss attributable to biosig technologies, inc | -20,372 | -1,914 | -3,915 | |
| Preferred stock deemed dividend | 0 | 24 | - | |
| Preferred stock dividend | 2 | 2 | 3 | |
| Net loss attributed to biosig technologies, inc. common shareholders | -20,374 | -1,940 | -3,918 | |
| Net loss per common share, basic | -0.74 | -0.12 | -0.3 | |
| Net loss per common share, diluted | -0.74 | -0.12 | -0.3 | |
| Weighted average number of common shares outstanding, basic | 27,706,780 | 16,200,928 | 12,916,272 | |
| Weighted average number of common shares outstanding, diluted | 27,706,780 | 16,200,928 | 12,916,272 | |
BioSig Technologies, Inc. (BSGM)
BioSig Technologies, Inc. (BSGM)